GESTODENE,ETHINYL ESTRADIOL
Background and Date of Approval
Gestodene and Ethinyl Estradiol are hormonal components commonly combined in oral contraceptive medications. The U.S. Food and Drug Administration (FDA) initially approved this combination on August 13, 2008.
Uses
Gestodene and Ethinyl Estradiol are used primarily for pregnancy prevention as an oral contraceptive. They also help regulate menstrual cycles, manage acne (especially hormonal acne), and treat conditions like polycystic ovary syndrome (PCOS). Additionally, they are used to alleviate symptoms of endometriosis and to reduce heavy or painful periods (dysmenorrhea).
How is it administered?
Gestodene and Ethinyl Estradiol are commonly taken orally in the form of a tablet, with one tablet usually taken once a day at the same time for 21 consecutive days. After completing the 21-day course, a 7-day break is observed, during which menstruation-like bleeding typically occurs. A new pack should be started after the 7-day break. The tablets can be taken with or without food, but it is important to take them at the same time each day to maintain consistency. If a dose is missed, it should be taken as soon as remembered, within 12 hours of the regular dose. If more than 12 hours have passed, refer to the product instructions or consult a healthcare provider for advice. Always follow the guidance of your healthcare provider regarding dosage and missed doses.
Side Effects
Common side effects include: Nausea or vomiting Headaches or migraine Breast tenderness or enlargement Mood changes or depression Weight gain or fluid retention Spotting or breakthrough bleeding (especially during the first few months of use) Decreased libido or sexual dysfunction Rare but serious side effects include: Blood clots (deep vein thrombosis, pulmonary embolism, stroke, or heart attack) Severe allergic reactions (rash, itching, swelling) Liver problems (jaundice, abnormal liver function tests) High blood pressure Vision problems (e.g., blurry vision or visual disturbances)
Warnings
Blood clots : There is an increased risk of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. This risk is higher in women who smoke, are over 35 years old, or have other risk factors for cardiovascular disease. Cancer risk : Long-term use may be associated with an increased risk of breast cancer and cervical cancer. Regular screening and monitoring are recommended. Liver conditions : This combination should be used with caution in women with a history of liver disease or hepatic tumours, as it may affect liver function. Pregnancy : This medication is not for use during pregnancy. It should be discontinued if pregnancy occurs. It is also not recommended during breastfeeding. Hormonal imbalances : Women with conditions like endometriosis, uterine fibroids, or polycystic ovary syndrome (PCOS) should use it cautiously and under medical supervision.
Precautions
Use with caution in women with a history of high blood pressure, diabetes, high cholesterol, or obesity, as these conditions increase cardiovascular risk. Regular blood pressure monitoring is advised. Inform your healthcare provider about any other medications, especially antibiotics or anti-seizure drugs, as they may interact. Women who smoke or are over 35 should be closely monitored for thromboembolic risks. Seek immediate medical attention for serious side effects, such as severe headaches, vision changes, or leg pain.
Word of Advice
Follow your healthcare provider's instructions for appropriate use of gestodene and ethinyl estradiol. Avoid smoking and notify your doctor of any pre-existing conditions, particularly cardiovascular or hepatic disorders. Regular monitoring and check-ups are necessary, especially if you develop any unusual symptoms. Do not miss doses and contact your healthcare provider promptly if you suspect serious adverse effects.
References
https://labeling.pfizer.com/ShowLabeling.aspx?id=14834 Täuber U, Kuhnz W, Hümpel M. Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive. https://pubmed.ncbi.nlm.nih.gov/2220966/ https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020713s010lbl.pdf https://www.sciencedirect.com/science/article/abs/pii/000293789091358J
Frequently Asked Questions
Is Gestodene, Ethinyl Estradiol a hormone?
Yes, Gestodene and Ethinyl Estradiol are synthetic hormones. Gestodene is a progestin (a synthetic form of progesterone), and Ethinyl Estradiol is an estrogen (a synthetic form of the natural hormone estrogen). Together, they regulate the menstrual cycle and prevent pregnancy.
Can Gestodene, Ethinyl Estradiol prevent pregnancy?
Yes, Gestodene and Ethinyl Estradiol are highly effective in preventing pregnancy when taken correctly. They work by preventing ovulation, thickening cervical mucus, and altering the uterine lining, making it difficult for sperm to fertilise an egg. When used as directed, the combination provides reliable contraception.
Does Gestodene, Ethinyl Estradiol stop periods?
Gestodene and Ethinyl Estradiol can reduce or stop periods in some women, especially during the first few months of use. This is due to the way the hormones regulate the menstrual cycle. However, breakthrough bleeding or spotting may still occur occasionally.
Does the Gestodene, Ethinyl Estradiol, change your body shape?
Gestodene and Ethinyl Estradiol may cause slight changes in body shape for some women, primarily due to fluid retention or changes in fat distribution. However, these effects are generally temporary and vary from person to person. If significant changes occur, it's advisable to consult a healthcare provider.
Does Gestodene, Ethinyl Estradiol cause weight gain?
Gestodene and Ethinyl Estradiol can cause weight gain in some women, though it is not a common side effect. Any weight increase is usually due to fluid retention or changes in appetite rather than fat accumulation. If significant weight gain occurs, it is important to consult a healthcare provider to assess the cause and consider alternative options.